Ouverture de l'appel JPIAMR – Transnational call on “Disrupting drug resistance using innovative design” (DRUID) 2022

Ouverture de l'appel JPIAMR – Transnational call on “Disrupting drug resistance using innovative design” (DRUID) 2022

Publié le 19 janvier 2022

Ouverture de l'appel JPIAMR – Transnational call on “Disrupting drug resistance using innovative design” (DRUID) 2022

Belgium (F.R.S.-FNRS) – Fédération Wallonie – Bruxelles critères d’éligibilité



  • Date limite de soumission des pré-propositions (soumission centralisée): 08 mars 2022, 14:00 CET.

  • Date limite de soumission e-space (obligation F.R.S.-FNRS) : 15 mars 2022, 14:00 CET


Project duration


The maximum amount of requested funding per project is 200.000 EUR for a total period of three years. If the project involves the recruitment of a PhD student, the project duration of the F.R.S.-FNRS sub-project could be up to four years.


Eligibility rules


All eligibility rules and criteria can be found in the PINT-MULTI regulations. This call is NOT co-funded (see article III.6).


Forms to be submitted


Applicants to F.R.S.-FNRS funding must provide basic administrative data by submitting an administrative application e-space within 5 working days after the general deadline of the JPIAMR call to be eligible. Please select the “PINT-MULTI” funding instrument when creating the administrative application. Proposals invited to the second stage will be able to complete the pre-proposal form and provide information for the full proposal upon validation by the F.R.S.-FNRS.


Non-permissible costs


“Overhead” is not an eligible cost. If the project is selected for funding, these costs will be subject to a separate agreement between the institution of the beneficiary and the F.R.S.-FNRS.


CONTACT PERSONS:


Please contact one of the persons below if you have questions regarding the above:
international@frs-fnrs.be
Florence Quist, 02 504 93 51
Joel Groeneveld, 02 504 92 70



For more info on the call, https://www.jpiamr.eu/calls/therapeutics-call-2022/